Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunxia Wang

Showing results (351-360 of 360) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 360 results.
British Journal of Cancer|November 14, 2018
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinomaVincenzo Mazzaferro, Bassel F El-Rayes, Michele Droz Dit Busset, et al.
Oncotarget|September 1, 2016
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinibLorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, et al.
Muscle & Nerve|September 19, 2012
A quantitative measure of handgrip myotonia in non-dystrophic myotoniaJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Dosage-sensitive <i>RBFOX2</i> autoregulation promotes cardiomyocyte differentiation by maturing the transcriptomeMengmeng Huang, Feria A Ladha, Yunxia Wang, et al.
Muscle & Nerve|September 8, 2018
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trialJeffrey M Statland, Dan Moore, Yunxia Wang, et al.
Tuberculosis (Edinburgh, Scotland)|March 17, 2016
Profiling the human immune response to Mycobacterium tuberculosis by human cytokine arrayTao Chen, Zhenyan Li, Li Yu, et al.
Neurology|October 15, 2017
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancerDavid E Gerber, Mark A Socinski, Joel W Neal, et al.
Science Translational Medicine|March 25, 2016
Targeting protein homeostasis in sporadic inclusion body myositisMhoriam Ahmed, Pedro M Machado, Adrian Miller, et al.
Frontiers in Medicine|April 3, 2026
Heterogeneous impact of tea consumption on COPD risk in smokers: insights from the PIFCOPD studyYijing Li, Jiping Liao, Ruiying Wang, et al.
Pageof 36

Showing results (351-360 of 360) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 360 results.
British Journal of Cancer|November 14, 2018
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinomaVincenzo Mazzaferro, Bassel F El-Rayes, Michele Droz Dit Busset, et al.
Oncotarget|September 1, 2016
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinibLorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, et al.
Muscle & Nerve|September 19, 2012
A quantitative measure of handgrip myotonia in non-dystrophic myotoniaJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Dosage-sensitive <i>RBFOX2</i> autoregulation promotes cardiomyocyte differentiation by maturing the transcriptomeMengmeng Huang, Feria A Ladha, Yunxia Wang, et al.
Muscle & Nerve|September 8, 2018
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trialJeffrey M Statland, Dan Moore, Yunxia Wang, et al.
Tuberculosis (Edinburgh, Scotland)|March 17, 2016
Profiling the human immune response to Mycobacterium tuberculosis by human cytokine arrayTao Chen, Zhenyan Li, Li Yu, et al.
Neurology|October 15, 2017
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancerDavid E Gerber, Mark A Socinski, Joel W Neal, et al.
Science Translational Medicine|March 25, 2016
Targeting protein homeostasis in sporadic inclusion body myositisMhoriam Ahmed, Pedro M Machado, Adrian Miller, et al.
Frontiers in Medicine|April 3, 2026
Heterogeneous impact of tea consumption on COPD risk in smokers: insights from the PIFCOPD studyYijing Li, Jiping Liao, Ruiying Wang, et al.
Pageof 36